To address whether blocking Axl signaling would improve GA effectiveness, we tested two clinical Axl inhibitors, BGB324 (Ben-Batalla et al., 2013) and warfarin, in combination with GA in PDA primary cell culture and KIC Rgs16::GFP reporter mice. The gene discussed is RGS16; the disease is Patent ductus arteriosus.